In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as a beacon of hope for millions affected by these ...

AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.

Please provide your email address to receive an email when new articles are posted on . Errors of refraction and strabismic amblyopia were the most common causes of low vision. Retinal diseases most ...

Researchers at the University of Twente and Radboudumc are developing a promising new model to enhance understanding of the ...

An AI segmentation system was able to identify changes in retinal segmented features based on optical coherence tomography (OCT) images. Diagnosing and monitoring retinal diseases is done through OCT, ...

Until now, it has been difficult to maintain retinal ganglion cells deep inside organoids over extended periods. The supply of nutrients and oxygen in the densely packed tissues is limited, leading to ...

The trial is funded through Abu Dhabi’s Healthcare Research and Innovation FundClinical development activities will commence at Cleveland Clinic ...

Nanoscope Therapeutics, Inc., a biotechnology company developing disease-agnostic therapies for vision loss caused by retinal degeneration, today announced that Japan's Ministry of Health, Labour and ...

Many people do not think much about their eyes when there is not something wrong with them (blurred vision, glare at night, ...